Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
DBMD Disease Information


Shigellosis

Navigation bar

 
 
Clinical Features Watery or bloody diarrhea, abdominal pain, fever, and malaise.
Etiologic Agent Four species of Shigella: boydii, dysenteriae, flexneri, and sonnei.
Incidence Approximately 14,000 laboratory confirmed cases of shigellosis and an estimated 448,240 total cases (85% due to S. sonnei) occur in the United States each year. In the developing world, S.flexneri predominates. Epidemics of S. dysenteriae type 1 have occurred in Africa and Central America with case fatality rates of 5-15%.
Sequelae Reiter's syndrome is a late complication of S. flexneri infection, especially in persons with the genetic marker HLA-B27. Hemolytic-uremic syndrome can occur after S. dysenteriae type 1 infection. Convulsions may occur in children; the mechanism may be related to a rapid rate of temperature elevation or metabolic alterations.
Transmission A small inoculum (10 to 200 organisms) is sufficient to cause infection. As a result, spread can easily occur by the fecal-oral route and occurs in areas where hygiene is poor. Epidemics may be foodborne or waterborne. Shigella can also be transmitted bu flies.
Risk Groups In the United States, groups at increased risk of shigellosis include children in child-care centers and persons in custodial institutions, where personal hygiene is difficult to maintain; Native Americans; orthodox Jews; international travelers; men who have sex with men; and those in homes with inadequate water for handwashing.
Surveillance All reported cases are laboratory-confirmed in states or at CDC. Shigellosis is a notifiable infectious disease.
Trends Decreasing incidence in cases since 1995; characteristically, S. sonnei causes large periodic outbreaks.
Challenges Increasing resistance to available antimicrobial agents among isolates acquired domestically and abroad; absence of effective vaccines; modifying handwashing behavior to control prolonged community-wide outbreaks; identifying targeted prevention measures in high-risk groups (e.g., Native Americans, Orthodox Jews, men who have sex with men, and children who attend daycare).
Opportunities A major initiative to strengthen laboratory, epidemiologic, and public health capacity to detect and respond to epidemic S.dysenteriae type 1 in southern Africa could be duplicated in other regions at risk. Partnerships with local health departments and communities may lead to investigations of transmission and new prevention materials. Subtyping of S. sonnei by pulsed field gel electrophoresis can improve outbreak detection and control.

December 2003

 
 
 
   
         

Accessibility | Privacy Policy Notice | FOIA

CDC Home | Search | Health Topics A-Z

This page last reviewed February 12, 2004

Centers for Disease Control and Prevention
National Center for Infectious Diseases
Division of Bacterial and Mycotic Diseases


 
Return to DBMD disease listing go to Additional Information go to General Information